
    
      The CP322 study is an investigation of non-CE marked intermittent catheters which will be
      conducted in Denmark. The study is a randomized, single blinded, cross-over investigation
      comparing two new catheters with a comparator catheter in 30 adult healthy volunteers.
    
  